ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 41 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,968,000 | -0.3% | 5,950,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $5,985,000 | -0.9% | 5,950,000 | 0.0% | 0.01% | -9.1% |
| Q1 2021 | $6,042,000 | -7.0% | 5,950,000 | 0.0% | 0.01% | -21.4% |
| Q4 2020 | $6,496,000 | +10.8% | 5,950,000 | +4.4% | 0.01% | 0.0% |
| Q3 2020 | $5,861,000 | -6.9% | 5,700,000 | 0.0% | 0.01% | -17.6% |
| Q2 2020 | $6,293,000 | +9.1% | 5,700,000 | 0.0% | 0.02% | -15.0% |
| Q1 2020 | $5,769,000 | -36.5% | 5,700,000 | -28.3% | 0.02% | -16.7% |
| Q4 2019 | $9,082,000 | +0.0% | 7,950,000 | 0.0% | 0.02% | -11.1% |
| Q3 2019 | $9,081,000 | -9.1% | 7,950,000 | -5.9% | 0.03% | -12.9% |
| Q2 2019 | $9,994,000 | +9.9% | 8,450,000 | +25.2% | 0.03% | +3.3% |
| Q1 2019 | $9,093,000 | +27.9% | 6,750,000 | 0.0% | 0.03% | +7.1% |
| Q4 2018 | $7,108,000 | -6.3% | 6,750,000 | -12.9% | 0.03% | 0.0% |
| Q2 2018 | $7,585,000 | -1.9% | 7,750,000 | -1.0% | 0.03% | -6.7% |
| Q1 2018 | $7,733,000 | +4.6% | 7,825,000 | +11.8% | 0.03% | +7.1% |
| Q4 2017 | $7,390,000 | +3.3% | 7,000,000 | +3.7% | 0.03% | -6.7% |
| Q3 2017 | $7,153,000 | +40.8% | 6,750,000 | +42.1% | 0.03% | +25.0% |
| Q2 2017 | $5,079,000 | +40.4% | 4,750,000 | +26.7% | 0.02% | +50.0% |
| Q1 2017 | $3,617,000 | – | 3,750,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|